Formulation and Drug Delivery

RESULTS BY SUB-TOPIC s s Search this topic Find It

FEATURED REPORTS

WHAT'S NEW

REPORTS BY SUBTOPIC

Dowpharma Contract Services
By Dowpharma
Product collateral
Dowpharma contract manufacturing services works with customers from drug development to commercialization to achieve the optimal balance of speed, economics and quality.

Preformulation Technical Notes: API Solubility Enhancement
By Cardinal Health
White paper
This white paper by CardinalHealth explains systematic approach for investigation of solubility behavior of active pharmaceutical ingredient (API).

API and excipient testing
By Cardinal Health
Application note
In this application note, Cardinal Health describes the physical testing of active pharmaceutical ingredients (APIs) and excipients and how it adds value to a formulation development program by enabling the most appropriate strategy to be selected.

Less is more in API process development
By EPCOT International
White paper
According to this white paper from EPCOT International Inc., U.S. manufacturers can simplify their processes and lower their costs to make active pharmaceutical ingredients.

Characterization of oligomeric materials developed for use as excipients in ...
By 3M Drug Delivery Systems
Application note
This application note from 3M Drug Delivery Systems describes the characterization of acetyloligolactic acid from a polymer science perspective, which characterizes polymers and oligomers based on average properties.

Sustained release suspension aerosol formulations with oligolactic acid
By 3M Drug Delivery Systems
Application note
This application note by 3M Drug Delivery Systems describes how oligolactic acids (OLAs), a family of designed excipients, offer advantages in either solution or suspension sustained release aerosol formulations.

Valves and Canisters for Metered Dose Inhalers
By 3M Drug Delivery Systems
Product collateral
<P>While providing the safety and efficacy of CFC-based MDIs, 3M’s HFAMDIs have a mist-like spray with reduced spray force. Doses are reliable and consistent, regardless of storage orientation. Tail-off profiles are significantly improved so patients receive predictable and effective dosing, even when the MDI canister is nearly empty.</P>

IsoAir Aerosol Particle Sensors
By Particle Measuring Systems
Product collateral
IsoAir sensors offer real-time particle monitoring giving quick notification of anomalies, .5 and 5.0 micron channels for GMP compliance, proven technology provides accurate data, and critical zone protection.

IsoAir PLUS Aerosol Particle Sensors
By Particle Measuring Systems
Product collateral
IsoAir PLUS sensors offer real-time particle monitoring giving quick notification of anomalies.

Achieving optimal particle size distribution in inhalation therapy
By Microfluidics Corp.
White paper
This paper addresses the concerns that pharmaceutical manufacturers have when attempting to achieve the correct particle size and uniformity for a drug that is to be administered via an inhalation device, and how high-shear fluid processing can overcome those concerns.

Compression and drug release characteristics of KLUCEL HPC controlled release...
By Hercules Inc.
White paper
This white paper by Hercules Inc. explains the compression and drug release characteristics of directly compressible KLUCEL hydroxypropylcellulose controlled release matrix systems.

Characteristics of directly compressible KLUCEL HPC controlled-release matrix...
By Hercules Inc.
White paper
This white paper by Hercules Inc. explains compression and drug release characteristics of directly compressible KLUCEL hydroxypropylcellulose (HPC) controlled-release matrix systems.

Intracytoplasmic Sperm Injection (ICSI)-Procedure and Equipment
Application note
In this application note, Eppendorf AG discusses procedure and equipment used in Intracytoplasmic Sperm Injection (ICSI).

There are currently no reports available for this topic.

Zydis Fast-Dissolve Technology
By Cardinal Health
Product collateral
Zydis is a unique, freeze-dried oral solid dosage form that can be swallowed without water, because it dissolves instantly on the tongue in less than 3 seconds.

Orphan drug development: A global perspective
By Fulcrum Pharma Developments
White paper
Fulcrum Pharma Developments Inc. provides an overview of global orphan drug development and describes the similarities and differences in the three major markets: Europe, U.S. and Japan.

Pharmacokinetics of orally administered pyridoxamine dihydrochloride in Type ...
By AAI Pharma Inc.
White paper
AAI Development Services reports on studies to evaluate the safety, tolerability and pharmacokinetics of oral Pyridorin in patients with Type 1 diabetes and diabetes-associated nepropathy.

Combination products: Navigating two FDA quality systems
By Microtest Laboratories
White paper
While combination products are experiencing dramatic growth, the convergence of drugs/biologics and devices brings a host of regulatory challenges. This paper addresses the critical issues in this process, including defining the FDA’s regulatory framework, reviewing new developments in FDA thinking, and developing effective quality assurance systems.

Zydis Fast-Dissolve Technology
By Cardinal Health
Product collateral
Zydis is a unique, freeze-dried oral solid dosage form that can be swallowed without water, because it dissolves instantly on the tongue in less than 3 seconds.

Solid dosage suite
By Rockwell Automation Inc.
Application note
In this application note, Rockwell Automation Inc. describes how its modular and flexible S88-based system speeds implementation of solid dosage systems with less risk.

How MDS Pharma Services creates dosage forms and transfers the technology to ...
By MDS Pharma Services
Case study
In this case study, MDS Pharma Services outlines how it created a new dosage form and manufacturing process for a global pharma company that wanted to replace a sugarcoated tablet with an immediate-release, aquaeous-film coated tablet produced by direct compression.

Stability Studies and Storage
By Azopharma Inc.
Product collateral
Core services at Azopharma for management of stability programs are geared towards high throughput production combines with detailed compliance strategies. Both storage and testing capabilities are fully compliant with ICH guidelines.

Solid Dose Manufacturing for Clinical or Small-Scale Commercial Manufacturing
By AAI Pharma Inc.
Product collateral
Many pharmaceutical companies have come to rely on AAIPharma’s solid dose manufacturing capabilities to get their critical clinical trial materials manufactured, packaged, labeled and distributed to the investigator sites on time.

Oral Solids Manufacturing
By Cardinal Health
Product collateral
Specializing in both clinical and commercial manufacturing, Cardinal Health offers oral solid dosage forms that can maintain product’s positive momentum throughout the production process.

Bioavailability and bioequivalence studies for orally administered drug ...
By FDA Center for Drug Evaluation and Research
White paper
This white paper by the FDA's Center for Drug Evaluation and Research (CDER) contains advice on how to meet the bioavailability and bioequivalence requirements set forth in 21 CFR part 320 as they apply to dosage forms intended for oral administration, including INDs, NDAs, ANDAs, and their supplements.

DelPouch: Unit-Dose Delivery System
By Cardinal Health
Product collateral
Cardinal Health introduces Delpounch, a unit-dose delivery system for lotions, creams, and ointments for topical applications.

Topical Technologies
By Cardinal Health
Product collateral
Cardinal Health offers a large portfolio of topical technologies including Microsponge and DelPouch. Scientists offer information, consultation and partnership to developers, manufacturers and marketers interested in pursuing different topical applications for molecules, compounds and products.

Transdermal drug formulation and process development
By 3M Drug Delivery Systems
White paper
This white paper by 3M Drug Delivery Systems explains aspects of transdermal drug delivery technology including patch, reservoir and multilaminate designs, and packaging and tape manufacturing processes.

Tailoring resources for the right solution
By Quintiles Transnational Corp.
Case study
In this case study, Quintiles Transnational recruits patients for a pharmaceutical company's study involving a unique transdermal delivery device and reduces the average turnaround time of site reports by 50 percent.

Characterization of oligomeric materials developed for use as excipients in ...
By 3M Drug Delivery Systems
Application note
This application note from 3M Drug Delivery Systems describes the characterization of acetyloligolactic acid from a polymer science perspective, which characterizes polymers and oligomers based on average properties.

Surface area of magnesium stearate: An excipient used in pharmaceuticals
By Micromeritics Instrument Corp.
Application note
This application note by Micromeritics Instrument Corp. describes sample preparation and analysis of magnesium stearate, widely used as an excipient in tableted drugs.

Excipio economics: A new approach for improving the efficiency of oral dosage...
By JRS Pharma
White paper
This white paper by JRS Pharma LP discusses a new approach, called excipio economics, to evaluating the economic impact of new excipients on the development and manufacturing of tablets.

The preparation of pellets with silicified microcrystalline cellulose by ...
By JRS Pharma
White paper
This paper by JRS Pharma LP explains the preparation of pellets with the excipient silicified microcrystalline cellulose (SMCC) by extrusion and spheronization.

.
ad

KnowPharma.com Copyright © 2008, Putman Media, Inc. All rights reserved.
Designated trademarks and brands are the property of their respective owners.
Use of this web site constitutes acceptance of the KnowPharma.com Terms and Conditions and Privacy Policy.
Site Map